Prevention in Volleyball Players

November 22, 2022 updated by: Camille Tooth, University of Liege

The Efficiency of a Warm-up Prevention Program in Volleyball Players

The objective of this study is to assess the interest and the efficiency of a warm-up prevention program on the prevalence of shoulder injuries in amateur volleyball players.

Around ten teams will be included in the study. They will be divided into two groups (blind): an intervention group and a control group.

A warm-up prevention program will implemented in the teams of intervention group. This program will have to be followed twice a week, at the beginning of the training session.

In both groups, shoulder injuries will be registered each month by an online questionnaire.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Around ten teams will be recruted among the clubs in the Province of Liege. They will be divided into two groups (blind): an intervention group and a control group.

Each month, both groups will be asked to fill in a form with the potential injuries they experienced during the past month.

  • Intervention group :

All the teams included in the intervention group will be asked to follow a warm-up prevention program (about 15 minutes) at least twice a week, at the beginning of the training session.

At the beginning of the season, one experimenter will go to the different clubs in order to present the program, to explain the exercises and to correct the players while doint the exercises.

During the season, the same experimenter will go to the clubs at regular intervals to make sure that the players are well doing the program and to assess the compliance.

- Control group :

The objective of the control group is to estimate the prevalence of shoulder injuries in a group without any prevention implementation. The players of this group will jus have to answer the monthly questionnaire about the potential injuries they experienced during the previous month.

Study Type

Interventional

Enrollment (Actual)

93

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Belgium
      • Namur, Belgium
        • Fédération de Volleyball Wallonie-Bruxelles

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

15 years to 35 years (Child, Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • volleyball players in Provincial level (P1-P2)
  • practicing volleyball at least 4 hours in a week
  • no "prevention routines"

Exclusion Criteria:

  • having a prevention program

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention group
The teams in the intervention group will have to follow a warm-up prevention program twice a week
Other: Prevention exercises
Participants will have to follow a warm-up prevention program (15 minutes) twice a week
No Intervention: Control group
The teams in the control group will have to reply each month to a questionnaire about the potential injuries they experienced during the previous month.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Prevalence of shoulder injuries
Time Frame: through study completion, an average of 1 year
The number of injuries the players experienced during the season
through study completion, an average of 1 year
Compliance with the program
Time Frame: through study completion, an average of 1 year
The number of time the players did the program during each month
through study completion, an average of 1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

University of Liege

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 15, 2021

Primary Completion (Actual)

June 30, 2022

Study Completion (Actual)

June 30, 2022

Study Registration Dates

First Submitted

March 9, 2020

First Submitted That Met QC Criteria

May 13, 2021

First Posted (Actual)

May 19, 2021

Study Record Updates

Last Update Posted (Actual)

November 23, 2022

Last Update Submitted That Met QC Criteria

November 22, 2022

Last Verified

November 1, 2022

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • Prevention VB

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Prevention

Clinical Trials on Prevention exercises

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Panama

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe